and obstructive sleep apnoea. Current medications included metoprolol 50 mg twice a day, moxonidine 200 µg at night, amlodipine 10 mg daily, indapamide 2.4 mg daily, and irbesartan 300 mg… Click to show full abstract
and obstructive sleep apnoea. Current medications included metoprolol 50 mg twice a day, moxonidine 200 µg at night, amlodipine 10 mg daily, indapamide 2.4 mg daily, and irbesartan 300 mg daily. Despite taking five antihypertensives, 24- hour blood pressure monitoring revealed a daytime average of 153/84 mmHg. Plasma aldosterone to renin ratio (ARR) was normal at 43 pmol/mU (reference interval [RI], < 70 pmol/mU; plasma aldosterone 536 pmol/L [RI, 70– 1090 pmol/L]; renin 12.6 mU/L [RI, 4.4– 46 mU/L]), with serum potassium 4.4 mmol/L (RI, 3.5– 5.2 mmol/L) and estimated glomerular filtration rate (eGFR) 47 mL/min/1.73 m 2 To facilitate further investigations, the medications were changed to verapamil sustained release 180 mg daily, prazosin 0.5 mg twice a day, and moxonidine 200 µg at night. Histopathology showing a 5 mm aldosterone- producing micronodule with strong positive staining for aldosterone synthase (CYP11B2 , cytochrome P450 family 11, subfamily B, member 2), a crucial enzyme in aldosterone synthesis
               
Click one of the above tabs to view related content.